| Valid Data Submission Method(s) | Measure Type | High Priority Measure? | NQS Domain | Specialty Measure Sets |
|---|---|---|---|---|
| Claims, Registry | Process | No | Effective Clinical Care | Hospitalists, Neurology |
Measure Description
Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) who were prescribed antithrombotic therapy at discharge
Instruction
This measure is to be reported for patients under active treatment for ischemic stroke or TIA at discharge from a hospital during the performance period. Part B claims data will be analyzed to determine the hospital discharge. It is anticipated that eligible clinicians who care for patients with a diagnosis of ischemic stroke or TIA in the hospital setting will submit this measure.
Denominator
All patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack(TIA)
Denominator Criteria (Eligible Cases):
Patients aged ≥ 18 years on date of enc unter
AND
Diagnosis for ischemic stroke or transient ischemic attack (ICD-10-CM): G45.0, G45.1, G45.2,G45.8,
G45.9, G46.0, G46.1, G46.2, I63.00, I63.011, I63.012, I63.013, I63.019, I63.02, I63.031, I63.032,
I63.033, I63.039, I63.09, I63.10, I63.111, I63.112, I63.113, I63.119, I63.12, I63.131, I63.132,
I63.133, I63.139, I63.19, I63.20, I63.211, I63.212, I63.213, I63.219, I63.22, I63.231, I63.232,
I63.233, I63.239, I63.29, I63.30, I63.311, I63.312, I63.313, I63.319, I63.321, I63.322, I63.323,
I63.329, I63.331, I63.332, I63.333, I63.339, I63.341, I63.342, I63.349, I63.39, I63.40, I63.411,
I63.412, I63.413, I63.419, I63.421, I63.422, I63.423, I63.429, I63.431, I63.432, I63.433, I63.439,
I63.441, I63.442, I63.449, I63.49, I63.50, I63.511, I63.512, I63.513, I63.519, I63.521, I63.523,
I63.531, I63.532, I63.533, I63.539, I63.541, I63.542, I63.543, I63.549, I63.59, I63.6, I63.8, I63.9
AND
Patient encounter during the performance period (CPT): 99238, 99239
AND NOT
Patient admitted for performance of elective carotid intervention: G9689
Numerator
Patients who were prescribed antithrombotic therapy at discharge
Numerator Instructions: If the consulting physician orders or agrees with a prior antithrombotic therapy order (from current or previous episodes of care during the performance period) and there is supporting documentation, report G8696.
Definitions:
Antithrombotic Therapy – Aspirin, combination of aspirin and extended-release dipyridamole, clopidogrel, ticlopidine, warfarin, low molecular weight heparin, dabigatran, rivaroxaban.**The above list of medications/drug names is based on clinical guidelines and other evidence. Thespecified drugs were selected based on the strength of evidence for their clinical
effectiveness. This list ofselected drugs may not be all-inclusive or current. Physicians and other health care professionals should refer tothe FDA’s web site page entitled “Drug Safety Communications” for up-to-date drug recall and alert information when prescribing medications.
Prescribed – May include prescription given to the patient for antithrombotic therapy at discharge
or antithrombotic therapy to be continued after discharge as documented in the discharge
medicationlist.
NUMERATOR NOTE: In order to meet the measure, antithrombotic therapy is to be prescribed at the time of discharge. If a physician other than the discharging physician (e.g., consulting physician) is reporting on this mentation that the prescription is being ordered for thepatient at the time of discharge, and included in the “medications prescribed at discharge”.
Numerator Options:
Performance Met: Antithrombotic therapy prescribed at discharge (G8696)
OR
Denominator Exception: Antithrombotic therapy not prescribed for documented reasons [(e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)]; (e.g., patient left against medical advice, other patient reason(s)) (G8697)
OR
Performance Not Met: Antithrombotic therapy was not prescribed at discharge, reason not given (G8698)